Sudarshan Pharma Industries Ltd Press Release Jul 14 2026

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Hemal Vasantrai Mehta

View Attachment